Nateglinide Other names: Nateglynide

Chemical formula: C₁₉H₂₇NO₃  Molecular mass: 317.429 g/mol  PubChem compound: 5311309

Therapeutic indications

Nateglinide is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 - 65 years old)

Nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nateglinide is contraindicated in the following cases:

Diabetes mellitus type 1 (C-peptide negative)

Diabetes mellitus type I

Pregnancy

Pregnancy

Lactation

Lactation

Severe hepatic impairment

Hepatic failure stage IV

Diabetic ketoacidosis

Diabetic ketoacidosis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: STARLIX Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈